Reminyl (Galantamine) is a treatment for patients with mild to moderate Alzheimer's disease (AD) and may be prescribed as soon as the diagnosis is made. In fact, the earlier the Reminyl (Galantamine) treatment is started, the better the effect may be. Medical studies have indicated that early Reminyl (Galantamine) treatment can result in ongoing effects on cognition (memory, thinking) and other aspects of daily life.
Reminyl (Galantamine) is available in 4-mg, 8-mg and 12-mg tablets and oral solution (4 mg/mL). Reminyl (Galantamine) should be taken twice a day, preferably with the morning and evening meal. Patients and caregivers should be advised to ensure adequate fluid intake during treatment. It is recommended that Reminyl (Galantamine) treatment start with 4 mg (white tablets) twice a day for at least 4 weeks and then continue with 8 mg (pink tablets) twice a day for at least 4 weeks. After 4 weeks of treatment with 8 mg twice a day, your doctor will evaluate the effects of Reminyl (Galantamine) and decide if Reminyl (Galantamine) treatment should continue with 8 mg twice a day or be increased to 12 mg (orange-brown tablets) twice a day.
Reminyl side effects, that may go away during treatment, include nausea, diarrhea, vomiting, stomach upset, loss of appetite, weight loss, or dizziness. If Reminyl side effects continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience Reminyl side effects like slow heartbeat. If you notice other Reminyl side effects not listed above, contact your doctor, nurse, or pharmacist.